Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 9101–9150 of 33127
On May 30, 2024, Jeff Newell and Michael L. Peterson each voluntarily resigned as a directors of the Company.
Zachary B. Fleming tendered his resignation as the Chief Executive Officer of Sanara MedTech Inc. (the “Company”), effective as of such date
On May 23, 2024, the Company and Ophir Sternberg entered into a Confidential Separation Agreement and General Release (the “Separation Agreement”), pursuant to which Mr. Sternberg resigned (the “Resignation”) as Executive Chairman of the Board and a Class C member of the Board of Directors (the “Board”) of the Company, effective immediately
On May 23, 2024, Mr. Kevin Schubert and the Company entered into a General Release and Separation Agreement (the “Separation Agreement”) wherein Mr. Schubert resigned from his role as Chief Financial Officer of Rubicon Technologies, Inc. (the “Company”), effective June 1, 2024.
On May 29, 2024, Portillo’s Inc. (the “Company”) announced that Derrick Pratt will depart from his role as the Company’s Chief Operating Officer, effective June 30, 2024.
Thomas J. Hansen, who served as a director of Terex Corporation (the “Company”) since 2008, did not stand for reelection at the Company’s 2024 Annual Meeting and therefore retired as a member of the Board of Directors effective May 23, 2024.
On May 29, 2024, Payoneer Global Inc. (the “Company”) announced that Arnon Kraft is expected to depart as Chief Operating Officer of the Company, on June 30, 2024 (the “Transition Date”).
The Company’s current Chief Operating Officer, Tony Gingiss, has agreed to provide strategic advisory services to the Company until his departure from the Company on July 15, 2024
As previously reported, Ms. Wadsten communicated her intention to the Company to retire as of June 3, 2024.
On May 22, 2024, the Board of Directors (the “Board”) of First Capital, Inc. (the “Company”) accepted the resignation of Michael L. Shireman from the Board.
On May 28, 2024, the Board of Directors of the general partner (the “General Partner”) of Black Stone Minerals, L.P. (the “Partnership”) and Evan Kiefer, Senior Vice President, Chief Financial Officer, and Treasurer of the General Partner, agreed that Mr. Kiefer would depart his current roles at the general partner effective May 28, 2024.
Effective June 10, 2024 (the “Separation Date”), Christopher Krawtschuk will depart bluebird bio, Inc. (the “Company”) and cease serving as Chief Financial Officer and principal accounting officer.
Following the voting on Proposal 1 (as listed below in Item 5.07) at the Annual Meeting on May 23, 2024, Roger Stoll's previously announced retirement from the Board took effect.
On May 22, 2024, Marius A. Haas informed Westlake Corporation (the “Company”) of his decision to resign from the Board of Directors of the Company in order to focus on BayPine Capital, a private equity investment company of which he is a founding partner.
On May 23, 2024, the board of directors of the Company (the “ Board ”) accepted the resignation of Nicholas Parker as a member of the Board and all committees thereof, effective as of May 23, 2024.
the April 14, 2023 resignation of Bradley J. Muth, age 68, from the offices of President and Chief Executive Officer.
On May 24, 2024, Tom McKinlay, Chief Executive Officer of the Company, informed the Company he will retire as Chief Executive Officer of the Company, effective September 30, 2024.
Effective May 21, 2024, Christopher H. Constable resigned as a member of board of directors of Brownie’s Marine Group, Inc.
On May 24, 2024, Lixte Biotechnology Holdings, Inc. (the “Company”) provided notice to Dr. James Miser that it has elected not to renew the employment agreement between the Company and Dr. Miser pursuant to which Dr. Miser has served as the Company’s Chief Medical Officer.
As previously announced, effective April 30, 2024, Monica Diaz Brickell left AXIL Brands, Inc. (the “Company”), including her position as the Chief Financial Officer of the Company.
Mr. Ondrof will continue to serve as Strategic Advisor to the Company through January 31, 2025 and will retire on such date.
In accordance with the ONE Gas, Inc. (the “Company”) director retirement policy as set forth our By-Laws and Corporate Governance Guidelines, Robert B. Evans and Douglas H. Yaeger retired from the Board of Directors effective May 23, 2024, immediately prior to the annual meeting of shareholders.
In accordance with the ONE Gas, Inc. (the “Company”) director retirement policy as set forth our By-Laws and Corporate Governance Guidelines, Robert B. Evans and Douglas H. Yaeger retired from the Board of Directors effective May 23, 2024, immediately prior to the annual meeting of shareholders.
On May 23, 2024, Andrew Lapham notified the Board of Directors (the “Board”) of Loop Industries, Inc. (the “Company”) that he plans to retire and not stand for re-election as director at the Company’s Annual Meeting of Stockholders to be held on June 28, 2024 (the “Annual Meeting”).
On May 23, 2024, Robert Enslin informed UiPath, Inc. (the “Company”) of his resignation from the Board of Directors of the Company (the “Board”) and from his position as Chief Executive Officer (“CEO”) of the Company, effective June 1, 2024
On May 23, 2024, Robert Enslin informed UiPath, Inc. (the “Company”) of his resignation from the Board of Directors of the Company (the “Board”) and from his position as Chief Executive Officer (“CEO”) of the Company, effective June 1, 2024
Mark C. Fuller, President and Chief Executive Officer ("CEO") of Castellum, Inc. (the "Company") will be stepping down from those positions effective July 1, 2024 to pursue other interests.
Stephen D. Griffin, Senior Vice President and Chief Financial Officer of VSE Corporation (the “Company”), notified the Company of his decision to resign from his positions with the Company, effective May 29, 2024
On May 21, 2024, the Company announced that Todd Zipper, Executive Vice President & General Manager, Talent, and a named executive officer, will cease his employment with the Company, effective as of the closing of the sale of John Wiley & Sons, Inc. emerging talent and reskill training business, Wiley Edge (the “Business”), to Inspirit (the “Transaction”)
On May 24, 2024, O. James Sterling tendered his resignation from his position as the Chief Financial Officer of Renalytix plc (the “ Company ”).
William Moreton notified the Company that he intends to resign from the Board for personal reasons effective May 28, 2024.
Daniel Pikora, former Chief Operating Officer, who resigned from the role on May 21, 2024 and will pursue opportunities outside the Company.
On May 28, 2024, Farmland Partners Inc. (the “Company”) announced that the Company and James Gilligan, the Company’s Chief Financial Officer and Treasurer, mutually agreed to separate.
On May 23, 2024, Richard M. Lucas notified Walker & Dunlop, Inc. (the “Company”) of his decision to resign from his position as Executive Vice President, General Counsel and Secretary, effective immediately.
On May 28, 2024, Vered Bisker-Leib, PhD, MBA, resigned as Chief Executive Officer (Principal Executive Officer and Principal Financial and Accounting Officer) and resigned as a member of the Board of Directors, of Compass Therapeutics, Inc. (the “Company”) effective the same date.
Terence M. Berge, Vice President, Corporate Controller, informed CONMED Corporation (the “Company”) that he plans to retire as of June 30, 2024.
Dr. Ho informed the Board of Directors of the Company (the “Board”) of her decision to resign as a director of the Company, effective upon the expiration of Dr. Ho’s term of service on the Initial Term Date.
Kevin C. Gorman, Ph.D. will retire as Neurocrine’s President and Chief Executive Officer effective as of October 11, 2024 (the “Transition Date”).
Effective May 23, 2024 (the “Effective Date”), Shaojun Sun resigned from the Board of Directors (the “Board”) of Power Solutions International, Inc.
On May 28, 2024, American Airlines Group Inc. (the “Company”) announced that Vasu Raja, Chief Commercial Officer of the Company, will depart the Company in June 2024.
On May 28, 2024, Justin Tichy notified Petco Health and Wellness Company, Inc. (the “Company”) of his resignation from his position as Chief Operating Officer of the Company, effective June 8, 2024.
In addition, on May 28, 2024, the Board further approved the termination of Amy College’s role as the Company’s Chief Merchandising and Supply Chain Officer, effective as of such time.
As of May 24, 2024, the Company terminated all of its employees and executive officers, including Chief Executive Officer and Co-Founder Clint Sever, Chief Business Officer Chris Achar and Chief Accounting Officer Randall Pollard.
As of May 24, 2024, the Company terminated all of its employees and executive officers, including Chief Executive Officer and Co-Founder Clint Sever, Chief Business Officer Chris Achar and Chief Accounting Officer Randall Pollard.
On May 24, 2024, each of the members of the Company’s board of directors, Chris Achar, Joanne Bradford, Carole Faig, Josh Ghaim, Sachin Jain and Maria Martinez (together, the “Remaining Directors”), provided notice of his or her resignation from the Board and all committees thereof, effective upon the Company’s submission of the Petition.
On May 24, 2024, each of the members of the Company’s board of directors, Chris Achar, Joanne Bradford, Carole Faig, Josh Ghaim, Sachin Jain and Maria Martinez (together, the “Remaining Directors”), provided notice of his or her resignation from the Board and all committees thereof, effective upon the Company’s submission of the Petition.
On May 24, 2024, each of the members of the Company’s board of directors, Chris Achar, Joanne Bradford, Carole Faig, Josh Ghaim, Sachin Jain and Maria Martinez (together, the “Remaining Directors”), provided notice of his or her resignation from the Board and all committees thereof, effective upon the Company’s submission of the Petition.
On May 24, 2024, each of the members of the Company’s board of directors, Chris Achar, Joanne Bradford, Carole Faig, Josh Ghaim, Sachin Jain and Maria Martinez (together, the “Remaining Directors”), provided notice of his or her resignation from the Board and all committees thereof, effective upon the Company’s submission of the Petition.
On May 24, 2024, each of the members of the Company’s board of directors, Chris Achar, Joanne Bradford, Carole Faig, Josh Ghaim, Sachin Jain and Maria Martinez (together, the “Remaining Directors”), provided notice of his or her resignation from the Board and all committees thereof, effective upon the Company’s submission of the Petition.
As of May 24, 2024, the Company terminated all of its employees and executive officers, including Chief Executive Officer and Co-Founder Clint Sever, Chief Business Officer Chris Achar and Chief Accounting Officer Randall Pollard.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.